Viromed Company Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Viromed Company Ltd with three other
pharmaceutical manufacturers in Asia:
Reber Genetics Co Ltd
sales of 30.33 million Taiwanese Dollars [US$1.01 million]
Solasia Pharma KK
(410.85 million Japanese Yen [US$3.71 million]
of which 100%
was Pharmaceutical busi), and
(3.22 billion Korean Won [US$2.99 million]
During the year ended December of 2017, sales at
Viromed Company Ltd were 3.16 billion Korean Won (US$2.93 million).
decrease of 53.9%
versus 2016, when the company's sales were 6.84 billion Korean Won.